Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases
出版年份 2018 全文链接
标题
Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases
作者
关键词
-
出版物
Frontiers in Immunology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-03-19
DOI
10.3389/fimmu.2018.00575
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mutations in the adaptor-binding domain and associated linker region of p110δ cause Activated PI3K-δ Syndrome 1 (APDS1)
- (2017) Lucie Heurtier et al. HAEMATOLOGICA
- Early diagnosis of PI3Kδ syndrome in a 2 years old girl with recurrent otitis and enlarged spleen
- (2017) F. Saettini et al. IMMUNOLOGY LETTERS
- Novel PIK3CD mutations affecting N-terminal residues of p110δ cause activated PI3Kδ syndrome (APDS) in humans
- (2017) Andrew J. Takeda et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study
- (2017) Tanya I. Coulter et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD
- (2017) Alina E. Dulau Florea et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas
- (2017) Braden D. Siempelkamp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Autosomal Recessive Agammaglobulinemia Due to a Homozygous Mutation in PIK3R1
- (2017) Paoyun Tang et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Variant PIK3R1 Hypermorphic Mutation and Clinical Phenotypes in a Family with Short Statures, Mild Immunodeficiency and Lymphoma
- (2017) Fabian Hauck et al. KLINISCHE PADIATRIE
- Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells
- (2017) Mara Compagno et al. NATURE
- PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α
- (2017) Lauren M. Thorpe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Conformational disruption of PI3Kδ regulation by immunodeficiency mutations inPIK3CDandPIK3R1
- (2017) Gillian L. Dornan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors
- (2017) Klemens Hoegenauer et al. ACS Medicinal Chemistry Letters
- Mutations in the adaptor-binding domain and associated linker region of p110δ cause Activated PI3K-δ Syndrome 1 (APDS1)
- (2017) Lucie Heurtier et al. HAEMATOLOGICA
- De novo PIK3R1 gain-of-function with recurrent sinopulmonary infections, long-lasting chronic CMV-lymphadenitis and microcephaly
- (2016) Michaela Kuhlen et al. CLINICAL IMMUNOLOGY
- De novo PIK3R2 variant causes polymicrogyria, corpus callosum hyperplasia and focal cortical dysplasia
- (2016) Gaetano Terrone et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Phosphatase and tensin homolog ( PTEN ) mutation can cause activated phosphatidylinositol 3-kinase δ syndrome–like immunodeficiency
- (2016) Yuki Tsujita et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature
- (2016) Slavé Petrovski et al. JOURNAL OF CLINICAL IMMUNOLOGY
- The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326)
- (2016) Timothy P. Heffron et al. JOURNAL OF MEDICINAL CHEMISTRY
- PI3Kγ is a molecular switch that controls immune suppression
- (2016) Megan M. Kaneda et al. NATURE
- Coincident signals from GPCRs and receptor tyrosine kinases are uniquely transduced by PI3Kβ in myeloid cells
- (2016) Daniel M. Houslay et al. Science Signaling
- Coincident signals from GPCRs and receptor tyrosine kinases are uniquely transduced by PI3Kβ in myeloid cells
- (2016) Daniel M. Houslay et al. Science Signaling
- Probing the dynamic regulation of peripheral membrane proteins using hydrogen deuterium exchange-MS (HDX-MS)
- (2015) O. Vadas et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Activating PI3Kδ mutations in a cohort of 669 patients with primary immunodeficiency
- (2015) M. Elgizouli et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma
- (2015) Q. Yang et al. CLINICAL CANCER RESEARCH
- Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next-generation sequencing study
- (2015) Ghayda M Mirzaa et al. LANCET NEUROLOGY
- Synergy in activating class I PI3Ks
- (2015) John E. Burke et al. TRENDS IN BIOCHEMICAL SCIENCES
- Regulation of the PI3K pathway through a p85α monomer–homodimer equilibrium
- (2015) Lydia WT Cheung et al. eLife
- Autoinhibition of Bruton's tyrosine kinase (Btk) and activation by soluble inositol hexakisphosphate
- (2015) Qi Wang et al. eLife
- Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110 , for relapsed/refractory chronic lymphocytic leukemia
- (2014) J. R. Brown et al. BLOOD
- Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase- , as therapy for previously treated indolent non-Hodgkin lymphoma
- (2014) I. W. Flinn et al. BLOOD
- A phase 1 study of the PI3K inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)
- (2014) B. S. Kahl et al. BLOOD
- Exome sequencing identifies a novel mutation in PIK3R1 as the cause of SHORT syndrome
- (2014) Clea Bárcena et al. BMC Medical Genetics
- Naturally Occurring Neomorphic PIK3R1 Mutations Activate the MAPK Pathway, Dictating Therapeutic Response to MAPK Pathway Inhibitors
- (2014) Lydia W.T. Cheung et al. CANCER CELL
- Gain of Function Mutations of PIK3CD as a Cause of Primary Sclerosing Cholangitis
- (2014) Heather N. Hartman et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Mutations in PIK3CD Can Cause Hyper IgM Syndrome (HIGM) Associated with Increased Cancer Susceptibility
- (2014) M. C. Crank et al. JOURNAL OF CLINICAL IMMUNOLOGY
- RAS interaction with PI3K p110α is required for tumor-induced angiogenesis
- (2014) Miguel Manuel Murillo et al. JOURNAL OF CLINICAL INVESTIGATION
- A human immunodeficiency caused by mutations in the PIK3R1 gene
- (2014) Marie-Céline Deau et al. JOURNAL OF CLINICAL INVESTIGATION
- Heterozygous splice mutation inPIK3R1causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K
- (2014) Carrie L. Lucas et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
- (2014) Khaled Ali et al. NATURE
- PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
- (2014) Ajay K. Gopal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- PIK3R1 Mutations Cause Syndromic Insulin Resistance with Lipoatrophy
- (2013) Christel Thauvin-Robinet et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Mutations in PIK3R1 Cause SHORT Syndrome
- (2013) David A. Dyment et al. AMERICAN JOURNAL OF HUMAN GENETICS
- SHORT Syndrome with Partial Lipodystrophy Due to Impaired Phosphatidylinositol 3 Kinase Signaling
- (2013) Kishan Kumar Chudasama et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Signaling by the Phosphoinositide 3-Kinase Family in Immune Cells
- (2013) Klaus Okkenhaug Annual Review of Immunology
- Requirement for Interaction of PI3-Kinase p110α with RAS in Lung Tumor Maintenance
- (2013) Esther Castellano et al. CANCER CELL
- RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms
- (2013) Ralph Fritsch et al. CELL
- AKT3andPIK3R2mutations in two patients with megalencephaly-related syndromes: MCAP and MPPH
- (2013) K. Nakamura et al. CLINICAL GENETICS
- PIK3R1mutations in SHORT syndrome
- (2013) C. Schroeder et al. CLINICAL GENETICS
- Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency
- (2013) Carrie L Lucas et al. NATURE IMMUNOLOGY
- Regulation of Small GTPases by GEFs, GAPs, and GDIs
- (2013) Jacqueline Cherfils et al. PHYSIOLOGICAL REVIEWS
- Phosphoinositide 3-Kinase Gene Mutation Predisposes to Respiratory Infection and Airway Damage
- (2013) I. Angulo et al. SCIENCE
- Germline PIK3CA and AKT1 Mutations in Cowden and Cowden-like Syndromes
- (2012) Mohammed S. Orloff et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K
- (2012) Mary Ellen Conley et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA
- (2012) Marjorie J Lindhurst et al. NATURE GENETICS
- De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
- (2012) Jean-Baptiste Rivière et al. NATURE GENETICS
- Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110 (PIK3CA)
- (2012) J. E. Burke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- G Protein-Coupled Receptor-Mediated Activation of p110 by G Is Required for Cellular Transformation and Invasiveness
- (2012) H. A. Dbouk et al. Science Signaling
- Using Tandem Mass Spectrometry in Targeted Mode to Identify Activators of Class IA PI3K in Cancer
- (2011) X. Yang et al. CANCER RESEARCH
- PIK3R1 (p85 ) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer
- (2011) M. E. Urick et al. CANCER RESEARCH
- A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial Carcinomas
- (2011) Meghan L. Rudd et al. CLINICAL CANCER RESEARCH
- Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory Mechanism
- (2011) Xuxiao Zhang et al. MOLECULAR CELL
- Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases
- (2011) W-C Hon et al. ONCOGENE
- Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases
- (2011) Oscar Vadas et al. Science Signaling
- Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110α
- (2011) John E. Burke et al. STRUCTURE
- High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
- (2011) Lydia W.T. Cheung et al. Cancer Discovery
- Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation
- (2009) Bijay S. Jaiswal et al. CANCER CELL
- A frequent kinase domain mutation that changes the interaction between PI3K and the membrane
- (2009) D. Mandelker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of phosphoinositide 3-kinase expression in health and disease
- (2009) Klaartje Kok et al. TRENDS IN BIOCHEMICAL SCIENCES
- Helical domain and kinase domain mutations in p110 of phosphatidylinositol 3-kinase induce gain of function by different mechanisms
- (2008) L. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now